Lawmakers ask FDA for timeline on reclassifying hydrocodone

02/17/2013 | Hill, The · Pharmalot.com

Seven U.S. lawmakers asked the FDA to create a time frame for reclassifying hydrocodone drugs from Schedule III to Schedule II. The change would mean patients would need a physician's written prescription to be able to purchase the medications.

View Full Article in:

Hill, The · Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD